Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Xeljanz XR (tofacitinib XR)
i
Other names:
Cp-690,550 XR, CP-690550 XR
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
JAK inhibitor
Related drugs:
‹
Max-40279 (2)
ALXN2075 (2)
AT9283 (0)
TQ05105 (0)
Max-40279 (2)
ALXN2075 (2)
AT9283 (0)
TQ05105 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
JAK3 M511I
T Acute Lymphoblastic Leukemia
JAK3 M511I
T Acute Lymphoblastic Leukemia
tofacitinib XR
Sensitive: D – Preclinical
tofacitinib XR
Sensitive
:
D
tofacitinib XR
Sensitive: D – Preclinical
tofacitinib XR
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login